PL
CTKB icon

Parkwood LLC’s Cytek Biosciences CTKB Stock Holding History

Parkwood LLC’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-48,244
Closed -$412K – 155
2023
Q2 		$412K Buy
48,244
+17,332
+56% +$155K 0.08% 110
2023
Q1 		$284K Sell
30,912
-8,992
-23% -$96.7K 0.04% 132
2022
Q4 		$407K Sell
39,904
-2,432
-6% -$32.7K 0.06% 117
2022
Q3 		$623K Buy
42,336
+44
+0.1% +$572 0.09% 110
2022
Q2 		$454K Buy
42,292
+12,981
+44% +$129K 0.08% 115
2022
Q1 		$316K Sell
29,311
-3,016
-9% -$40.7K 0.05% 117
2021
Q4 		$528K Buy
+32,327
New +$677K 0.09% 91

Other funds holding CTKB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Parkwood LLC's CTKB Position: Q3 2023 in Review

Parkwood LLC sold out of Cytek Biosciences (CTKB) in Q3 2023, closing a stake of 48,244 shares — an estimated $412K sold.

Parkwood LLC first reported a position in CTKB in Q4 2021 and held it in 7 quarters. The position peaked at $623K in Q3 2022. 106 funds tracked by Wall St. Rank hold CTKB as of Q3 2023.

  • Parkwood LLC reported no remaining Cytek Biosciences position as of Q3 2023 after selling out during the quarter.
  • Parkwood LLC sold 48,244 Cytek Biosciences shares in Q3 2023, an estimated $412K.
  • Parkwood LLC first reported a position in Cytek Biosciences in Q4 2021 and held it in 7 quarters.
  • Parkwood LLC's Cytek Biosciences position peaked at $623K in Q3 2022.
  • 106 funds tracked by Wall St. Rank held Cytek Biosciences as of Q3 2023.

Based on Parkwood LLC's 13F filing for Q3 2023, filed 14 Nov 2023.